About NSTA - National Spasmodic Torticollis Association

Archive by Author

Jay A. Van Gerpen, M.D.

09 Oct
Dr. JayVanGerpen

2012 Symposium Guest Speakers Jay A. Van Gerpen, M.D. Assistant Professor of Neurology at the Mayo Clinic Florida Dr. Van Gerpen is an Assistant Professor of Neurology at the Mayo Clinic Florida in Jacksonville. Dr. Van Gerpen graduated from the Vanderbilt University School of Medicine in Nashville Tennessee. He completed neurology residency at the University […]

Latest News

03 Oct

Dissertation on “Cervical Dystonia and the Black Community.” February 15, 2012 My Life with Cervical Dystonia! My name is Karen Chandler and I have cervical dystonia. I was born in Panama (Afro-Hispanic and I do not speak lick of Spanish, lol) and raised sin California, Michigan, and Florida. I was diagnosed with CD while I […]

News / Pharmaceuticals

03 Oct

Merz Pharmaceuticals Receives J-Code For Xeomin (incobotulinumtoxinA) January 10, 2012 Permanent Product-Specific Code Will Help Simplify Billing And Reimbursement GREENSBORO, N.C., January 4, 2012 /PRNewswire/ — Merz Pharmaceuticals, LLC, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific Healthcare Common Procedure Coding System (HCPCS) billing code, J0588 “INJECTION, INCOBOTULINUMTOXIN […]

Special Events

02 Oct

2011 NSTA Symposium Information Las Vegas, Nevada – October 22nd and 23rd December 5, 2011 The 2011 NSTA symposium in Las Vegas, Nevada has passed and I am happy to report it was a huge success! We had over 130 people in attendance and the room was packed! We had so many people registering at […]

News & Events

01 Oct

Programs Feature Simple Enrollment and Meaningful Financial Assistance March 8, 2011 Allergan, Inc. is seeking patients who are or will be receiving onabotulinumtoxinA injections for the treatment of cervical dystonia for potential observational study participation. Eligible patients may receive a patient stipend for their participation. The CD-PROBE Study is a Multi-center, Prospective, Naturalistic, Observational Registry of Cervical […]

“Ipsen Observational Registry Study”

01 Oct

March 9, 2011 Ipsen, manufacturer of Dysport for Injection (also known in the US as abobotulinumtoxinA neurotoxin), is contacting physicians to conduct an observational registry stud. The goal of the registry, ANCHOR-CD, is to collect and evaluate typical treatment response information from cervical dystonia patients currently being treated with market-available Dysport.  The registry will recruit up to 400 […]

News | Merz Pharmaceuticals….

29 Sep

Merz Pharmaceuticals Introduces Comprehensive Programs To Provide Patients With Financial Assistance For Xeomin® (incobotulinumtoxinA) Programs Feature Simple Enrollment And Meaningful Financial Assistance Greensboro, N.C., March 8, 2011/PRNewswire/ – Merz Pharmaceuticals today announced the launch of two programs to provide financial assistance to patients for their treatment with Xeomin (incobotulinumtoxinA). XEOMIN is a botulinum toxin type […]

San Diego, California

22 Sep

Dystonia Support & Advocacy Group of San Diego County Meeting The Dystonia Medical Research Foundation (DMRF), in partnership with the Dystonia Support & Advocacy Group of San Diego County, is planning an exciting event on Sat., 11/3/18. They are holding the first-ever DYSTONIA DAY AT THE SAN DIEGO ZOO to help create more awareness for dystonia and also to […]

Los Angeles, California

20 Sep

Dystonia Support Group The Los Angeles Dystonia Support Group invites you to join us at our next meeting Date/Time: Saturday, 7/28 from 1-3:00 p.m. Guest Presenter: Susie Yong, Rep. from Ipsen Biopharmaceuticals (makers of DYSPORT) Location: Cedars-Sinai Medical Center Harvey Morse Conference Center 8701 Gracie Allen Dr., South Tower, Plaza Level Conference Rooms 1 & […]